Predictive Oncology Stock (NASDAQ: POAI) stock price, news, charts, stock research, profile.
Open | $1.06 |
Close | - |
Volume / Avg. | 39.64K / 1.80M |
Day Range | 1.03 - 1.09 |
52 Wk Range | 0.89 - 6.46 |
Market Cap | $4.23M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.3% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Predictive Oncology (NASDAQ:POAI) through any online brokerage.
Other companies in Predictive Oncology’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Bluejay Diagnostics (NASDAQ:BJDX) and Venus Concept (NASDAQ:VERO).
There is no analysis for Predictive Oncology.
There is no analysis for Predictive Oncology to provide a consensus price target.
The stock price for Predictive Oncology (NASDAQ: POAI) is $1.03 last updated Today at July 22, 2024 at 9:05 AM EDT.
There are no upcoming dividends for Predictive Oncology.
Predictive Oncology’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Predictive Oncology.
Predictive Oncology is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.